Finland Joins Other Scandinavian Countries In Pause of Moderna COVID-19 Vaccine in Men Under 30 Due to Potential Health Issues

While the researchers felt that reaction to the Moderna jab was the likely cause of the patient’s thrombosis, they still felt that the benefits of receiving the vaccine outweighed the potential hazards.
A Moderna spokesperson issued a statement on Wednesday in response to Sweden and Denmark’s decision to limit the use of their vaccine. File photo: Giovanni Cancemi, Shutter Stock, licensed.

EUROPE – Finland announced on Thursday that they are jointing fellow Scandinavian countries Sweden and Denmark in limiting their use of the Moderna COVID-19 Vaccine due to potentially serious side effects that can occur in young men who get the jab.

The use of the Moderna vaccine will be paused for man under the age of 30 in favor of Pfizer’s vaccine, according to Finnish Health Institute Director Mika Salminen, who noted that this group was at a higher risk than others of developing myocarditis, which is inflammation of the heart muscle.

Salminen cited an unpublished “Nordic study involving Finland, Sweden, Norway and Denmark” that indicated teen and young adult males were more susceptible to myocarditis brought on by the Moderna jab.


Big Tech is using a content filtering system for online censorship. Watch our short video about NewsGuard to learn how they control the narrative for the Lamestream Media and help keep you in the dark. NewsGuard works with Big-Tech to make it harder for you to find certain content they feel is 'missing context' or stories their editors deem "not in your best interest" - regardless of whether they are true and/or factually accurate. They also work with payment processors and ad-networks to cut off revenue streams to publications they rate poorly by their same bias standards. This should be criminal in America. You can bypass this third-world nonsense by signing up for featured stories by email and get the good stuff delivered right to your inbox.

Swedish and Danish health officials had already announced on Wednesday – one day prior to Finland’s announcement – that they would be pausing their use of the Moderna vaccine for males in that age range.

The Nordic study Moderna vaccine is due to be published within several weeks; preliminary data from the study has already been sent to the European Medicines Agency (EMA) to be assessed.

Currently, all Finland residents aged 12 and older are eligible to be vaccinated against COVID-19.

A Moderna spokesperson issued a statement on Wednesday in response to Sweden and Denmark’s decision to limit the use of their vaccine.

“These are typically mild cases and individuals tend to recover within a short time following standard treatment and rest,” they said. “The risk of myocarditis is substantially increased for those who contract COVID-19, and vaccination is the best way to protect against this.”

Comment via Facebook

Corrections: If you are aware of an inaccuracy or would like to report a correction, we would like to know about it. Please consider sending an email to and cite any sources if available. Thank you. (Policy)